Combination treatment with chemotherapy shows significant survival advantage over chemotherapy alone in pancreatic cancer.
Oncology
Advertisement
Analysis compares endosonography with mediastinoscopy in non-small cell lung cancer.
Advertisement
Environmental exposure to common chemicals found to inhibit tamoxifen efficacy in breast cancer patients.
Top news of the week in oncology, and cancer drug development.
Stiffness and hypoxia environments triggers the spread of breast cancer.
Researchers mimic the genetic mechanisms that block the development of Ras-dependent cancers.
Advertisement
Sunscreen can decrease the risk of melanoma by more than 30%.
Injection drug users carry a different set of challenges during treatment for hepatitis C virus.
Non-invasive liquid biopsies may be more a more effective alternative to tissue biopsies in patients with advanced lung cancer.
Top news of the day from across the health care landscape.
Advertisement
Pevonedistat, currently being tested in clinical trials, shows promise in killing melanomas and other cancer types.
Experimental combination therapy shows a significant survival advantage over chemotherapy alone in pancreatic cancer.
National Health Checkup finds that cancer beat out infectious diseases as the biggest concern.
Top news of the day from across the health care landscape.
New insights pave the way for future treatment developments of pancreatic ductal adenocarcinoma.
Although these interactions pose a threat to patients, pharmacists can play a large role in minimizing them.
Top news of the week in oncology, and cancer drug development.
New mouse study suggests that exposure to endocrine disrupting chemicals may cause resistance to tamoxifen therapy in some breast cancers.
Novel drug combined with gemcitabine chemotherapy shows promise
With few advancements in treatment options, a new immunotherapy treatment could lead to better outcomes in pancreatic cancer.
Top news of the day from across the healthcare landscape.
Top news of the day from across the health care landscape.
Dopamine receptor blockers found to inhibit pancreatic tumor growth.
Mice treated with drugs that block a dopamine receptor inhibited cancer growth.
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.
New findings demonstrating differing mechanisms may contribute to a better understanding of acquired resistance to combination drug treatment in cancer.
High body mass index linked to 10 types of cancer, including cancers of the breast, bowel, esophageal, and womb.
Top news of the day from across the healthcare landscape.
Top news of the day from across the health care landscape.
Chemotherapy combined with immunotherapy found to destroy dormant cancer cells.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
FDA Approval Signals Broader Recognition of Sexual Health in Aging Women
4
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
5
